Notícias Aditxt Inc - ADTX | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Aditxt Inc (ADTX)
Aditxt Inc (ADTX) Notícias

Aditxt Inc (ADTX)

0,0537

-0,008

(-12,97%)

Fechado 03 Março 6:00PM

Atrasado por 15 minutos

0,0526

-0,0011

( -2,05% )

Pré-mercado: 8:21AM

Atrasado por 15 minutos

Discussões em tempo real e ideias de negociação: Negocie com confiança com nossa poderosa plataforma.

Form 8-K - Current report

Aditxt Subsidiary Pearsanta Engages Dominari Securities for its Initial Public Offering, to Drive U.S. and Global Commercial Launch of Early Cancer Detection and Diagnosis Targeted for H2 2025

Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2025

Aditxt to Host Fireside Chat on Friday, February 21st at 11:30 AM Eastern Time

Form DEF 14A - Other definitive proxy statements

Form PRER14A - Preliminary Proxy Soliciting materials

Form 8-K - Current report

Aditxt’s Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection Platform

Form 8-K - Current report

Aditxt's Subsidiary Adimune Successfully Completes Preclinical Efficacy and Safety Studies for Its Immune Modulation Therapeutic ADI Platform, Advancing Toward First-in-Human Clinical Trials

Form PRE 14A - Other preliminary proxy statements

Form 8-K/A - Current report: [Amend]

Form 8-K/A - Current report: [Amend]

Form 8-K - Current report

Appili Therapeutics Announces Receipt of Final Court Order for Arrangement with Aditxt, Inc.

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições